Express News | Traws Pharma - on Nov 20, Receives Nasdaq Non-Compliance Notice as Co Fails to Meet Nasdaq Listing Rule 5550(B)(1)

Breakings06:04

Traws Pharma Faces Uncertain Future Amid Complex Onconova Merger

TipRanksNov 16 14:01

Traws Pharma Reports Promising Antiviral Drug Progress

TipRanksNov 15 12:15

Traws Pharma | 10-Q: Q3 2024 Earnings Report

SECNov 15 06:17 · Announcements

Traws Pharma GAAP EPS of -$8.81, Revenue of $0.06M In-line

Seeking AlphaNov 15 05:59

Traws Pharma 3Q Rev $57,000 >TRAW

Dow JonesNov 15 05:42